Medtech company specializing in joint-preserving knee implants

This business is a Dutch medical technology business, founded as a spin-off from an academic medical center and an international materials company. The business develops innovative orthopedic implants for patients with chronic knee pain following partial meniscus removal. Its mission is to provide patients with a better quality of life through joint-preserving solutions that reduce pain and restore mobility.

's Activities: The company develops an artificial meniscus prosthesis for patients with persistent pain following partial meniscus removal. The prosthesis acts as a new shock absorber in the knee, replacing the natural meniscus, to reduce pain and preserve the patient’s own knee for as long as possible. The business is conducting clinical trials in collaboration with hospitals and is working with international partners to obtain market approval.

Products & Services
Meniscus prostheses for both the medial and lateral sides of the knee, available in multiple sizes, with a corresponding fixation method and surgical instrument set.

What Makes This Business Unique
Unlike existing treatments, which are often limited to symptom relief or ultimately lead to a knee replacement, this prosthesis is designed to restore the biomechanical function of the meniscus. This can reduce pain, improve mobility, and potentially slow the progression of osteoarthritis, all while preserving the natural knee.

Market & Development
Target audience: orthopedic hospitals and orthopedic specialists, with partnerships with health insurers and patient organizations to ensure rapid implementation.

Current status
The implants are currently being evaluated in clinical trials at multiple hospitals, with successful surgeries already performed. The next step is a larger study for market approval in the U.S. and the EU. Development is funded through investments, grants, and innovation loans.

Founders & Team
The team consists of a founder with a medical background and many years of experience in the relevant field, a CEO with extensive experience in medical innovation, a COO with experience in clinical practice and business operations, a technical team of engineers, a part-time CFO, and an experienced, international Board of Directors.

Vision & Ambition
The company aims to set the global standard for joint-preserving treatments of meniscus-related knee conditions, with market approval and commercial rollout in multiple international markets as the next step.